Drawing for NPX

USPTO serial 98243882

NPX

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
NOVAKOVIC, MIROSLAV
Law office
TMEG LAW OFFICE 108

What this means

These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances. If abandonment was unintentional, consult counsel about a petition to revive. Otherwise file a new application if protection is still needed.

Status 602: These status codes mean the trademark application is abandoned and no longer pending. Common reasons include missing an Office Action response (600), filing without a valid basis (602), express abandonment by the applicant (604), or failure to respond to an examiner's inquiry (618). Revival may be possible in limited circumstances.

Need help with NPX?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

John Paul Oleksiuk

John Paul Oleksiuk Cooley LLP1299 Pennsylvania Avenue, NW, Suite 700Washington, DC 20004United States

Goods and services

ClassDescriptionStatusFirst use
009Biometric software for pupillometry and eye tracking measurement; Software as a medical device (SaMD), downloadable, for the diagnosis of balance disorders by recording, viewing, or analyzing pupillometry and eye movements tracking; Downloadable computer software for controlling and managing patient medical information; Pupillometry software; Medical devices, namely, pupilometers; Downloadable computer software using machine learning software for healthcare purposes; Downloadable computer software for medical apparatus used in pupillometry; Downloadable computer software for monitoring pupillometry biomarkers; Downloadable computer software for monitoring of neurological and neurodegenerative diseases; Computer hardware and downloadable software for pupillometry and collecting eye-tracking data; Computer hardware and software for analyzing and reporting pupillometry and eye-tracking data for the purposes of assessing individuals' performance, for making recommendations to improve individuals' performance, and for predictive modeling and analytics, for use in scientific research, and for use in marketingACTIVE—
042Laboratory Research in the field of pupillometry and eye tracking; Technological research in the field of pupillometry and eye tracking; Research relating to the development of new products and medical services; Design, engineering, research, development and testing service in the field of pupillometry and eye tracking for medical, scientific, and technological applications; Scientific and technological healthcare monitoring services including neurological status of patient, namely, in the field of pupillometry and eye tracking; Research and development services in connection with pupillometry and eye tracking; Medical research; Design and development of medical diagnostic apparatus; Scientific and medical research relating to the diagnosis and treatment of neurological and neurodegenerative diseases; Scientific and medical research relating to the development of non-invasive diagnostic methods based on pupillometry; Scientific and medical research, in the fields of Ophthalmology, Optics and Optometry; Scientific and medical research relating to searching of new biomarkersINACTIVE - INSUFFICIENT FEE RECEIVED—
044Medical services; Medical analysis services relating to the treatment and diagnosis of persons; Remote monitoring of medical data for medical diagnosis and treatment; Medical screening in the following fields: Diagnosis and treatment of neurological and neurodegenerative diseases; Medical services relating to pupillometry; Monitoring of patient condition using pupillometers; Medical services relating to disease progression by non-invasive methods; Medical services, in the fields of Ophthalmology, Optics and Optometric services; Medical diagnostic services relating to the use of pupillometry biomarkersINACTIVE - INSUFFICIENT FEE RECEIVED—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Jul 16, 2025TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jul 16, 2025ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Jul 16, 2025ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jul 16, 2025REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 16, 2025CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Jul 16, 2025COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Sep 17, 2024MAB2ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPONDThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Sep 17, 2024ABN2ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSEThe trademark application was abandoned because a required response or document was not filed by the deadline — usually a missed Office Action response. The application is dead unless a petition to revive is granted within a limited time.
Jun 3, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 3, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 3, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 22, 2024GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 22, 2024GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 22, 2024CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
May 22, 2024DOCKASSIGNED TO EXAMINER—
Nov 6, 2023NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 31, 2023NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance